China approved imports of Johnson & Johnson’s Tremfya (guselkumab), the National Medical Products Administration said in a notice.
Canada’s main pharmaceutical lobby group urged the government not to wait for drug shortages before responding to U.S. plans to import Canadian drugs, according to documents seen by Reuters.
